UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002614
Receipt No. R000003190
Scientific Title A Phase II study of Glypican-3(GPC3) peptide vaccine as adjuvant treatment for Hepatocellular carcinoma(HCC) after Surgical resection or Radiofrequency ablation(RFA)
Date of disclosure of the study information 2009/10/11
Last modified on 2014/10/14 09:10:35

No. Disposal Last modified on Item of update
1 Insert 2009/10/11 18:33:23
2 Update 2010/04/12 07:52:36 Organization
Organization
Organization
Institute
Organization1
3 Update 2012/10/11 09:37:07 Division name
Division name
Division name
Division name
Division name
Division name
Institute
Institute
Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2012/10/11 09:39:35 Last follow-up date
5 Update 2013/04/11 09:59:54 Recruitment status
6 Update 2013/10/15 12:27:33 Email
7 Update 2014/10/14 09:10:35 Recruitment status
Last follow-up date


Contact us.